EN
抗体药类似物
Research Grade Etrolizumab
All
TD-HY596036_1.jpg
  • CatalogTD-HY596036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsAnti-Beta7,PRO145223,RG7413,rhuMAbBeta7,CAS:1044758-60-2
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Etrolizumab


Catalog No. TD-HY596036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4, Gut homing receptor beta subunit, Integrin beta-7, ITGB7
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P13612 & P26010
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names Anti-Beta7,PRO145223,RG7413,rhuMAbBeta7,CAS:1044758-60-2
Background Etrolizumab (rhuMAb Beta7) is a gut-selective, anti-β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with Ki values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD).
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY596036_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Etrolizumab.